Consolidated Statement of Changes in Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Total Shareholders' Equity	Total Shareholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit and Cumulative Distributions	Accumulated Deficit and Cumulative Distributions Cumulative Effect, Period of Adoption, Adjustment	Non-controlling Interests	Non-controlling Interests Cumulative Effect, Period of Adoption, Adjustment	Total Equity	Total Equity Cumulative Effect, Period of Adoption, Adjustment	Class I Common Shares Common Stock	Class D Common Shares Common Stock	Class S Common Shares Common Stock
Beginning balance at Aug. 08, 2022			$ 0			$ 0	$ 0	$ 0		$ 0		$ 0		$ 0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued			768,088			767,326						768,088		316	14	432
Offering costs			(31,091)			(31,091)						(31,091)
Distribution reinvestment			3,375			3,372						3,375		1	0	2
Net loss	$ (881)		(1,384)					(1,384)		529		(855)
Other comprehensive income (loss)	3,368		3,678				3,678			(310)		3,368
Distributions declared on common shares			(11,828)					(11,828)				(11,828)
Common share repurchases					$ (49,707)
Redeemable common share measurement adjustment			(7)			(7)						(7)
Contributions from non-controlling interests										351,284		351,284
Distributions to and redemptions of non-controlling interests										(52,671)		(52,671)
Allocation to redeemable non-controlling interests			(42)			(42)						(42)
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership			5,294			5,294				(5,265)		29
Ending balance at Dec. 31, 2022	1,029,650	$ (7,157)	736,083	$ (5,162)		744,852	3,678	(13,212)	$ (5,162)	293,567	$ (1,995)	1,029,650	$ (7,157)	317	14	434
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued			1,247,005			1,245,790						1,247,005		701	32	482
Offering costs			(37,083)			(37,083)						(37,083)
Distribution reinvestment			40,679			40,639						40,679		19	1	20
Net loss	(21,004)		(19,907)					(19,907)		(888)		(20,795)
Other comprehensive income (loss)	142		(626)				(626)			890		264
Distributions declared on common shares			(94,357)					(94,357)				(94,357)
Common share repurchases			(38,425)		$ (38,425)	(38,387)						(38,425)		(21)	(2)	(15)
Amortization of restricted stock grants			170			170						170
Redeemable common share measurement adjustment			4			4						4
Contributions from non-controlling interests										126		126
Distributions to and redemptions of non-controlling interests										(41,832)		(41,832)
Allocation to redeemable non-controlling interests			(586)			(586)						(586)
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership			(7,044)			(7,044)				6,847		(197)
Ending balance at Dec. 31, 2023	$ 2,077,466		$ 1,820,751			$ 1,948,355	$ 3,052	$ (132,638)		$ 256,715		$ 2,077,466		$ 1,016	$ 45	$ 921